The first type of AD, known as “early‐onset” AD (EOAD), is linked to genetic changes, particularly those affecting presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein (APP) genes, which are involved in the synthesis of Aβ peptides. This evidence concerns the gene PSEN1 and Alzheimer disease.